Verification evidence is still being completed.
PDF / print export
Icosagen Group
Tartu, Estonia
- Verified lead
- Mart Ustav
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Founder and CEO
- 2026 technical specialization
- Antibody Discovery, Recombinant Protein Production, and cGMP Manufacturing
- Review cycle
- May 2026
- Full address
- Eerika tee 1, Õssu küla, Kambja vald, 61713 Tartumaa, Estonia
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Icosagen management page.
- Editorial note
- 1,600 m² cGMP protein-manufacturing facility with QMC platform and wave bioreactors up to 1,200 L for discovery-to-manufacturing continuity.
Antibody Discovery, Recombinant Protein Production, and cGMP Manufacturing
GMP Certified (Manufacturing), ISO 9001
1,600 m² cGMP protein-manufacturing facility with QMC platform and wave bioreactors up to 1,200 L for discovery-to-manufacturing continuity.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
1,600 m² cGMP protein-manufacturing facility with QMC platform and wave bioreactors up to 1,200 L for discovery-to-manufacturing continuity.
- Lead
- Mart Ustav (verified ↗)
- Address
- Eerika tee 1, Õssu küla, Kambja vald, 61713 Tartumaa, Estonia (source ↗)
- Compliance
- GMP Certified (Manufacturing) · ISO 9001
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Clinical CDMO and cGMP protein manufacturing
- Capabilities
- Recombinant Protein Production · Antibody Humanization · Stable Cell Line Dev
- Founded
- 1999
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Mart Ustav
Founder and CEO
Full addressEerika tee 1, Õssu küla, Kambja vald, 61713 Tartumaa, Estonia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Icosagen legal and data-processing pages naming Eerika tee 1, Õssu küla, Kambja vald as the company address.
Open sourceClinical CDMO and cGMP protein manufacturing
Tartu, Estonia. Antibody Discovery, Recombinant Protein Production, and cGMP Manufacturing. Review completed on 14 Mar 2026.
State Agency of Medicines (Estonia)
GMP Certified (Manufacturing), ISO 9001
Latest public certification
Icosagen cGMP production facility disclosure: Operational 2024, active in 2026 review
Icosagen InvestEU / EIB release on the new cGMP production facility.Antibody Discovery, Recombinant Protein Production, and cGMP Manufacturing
1,600 m² cGMP protein-manufacturing facility with QMC platform and wave bioreactors up to 1,200 L for discovery-to-manufacturing continuity.
Related companies
Editorial note
Icosagen now publicly ties its Tartu operating profile to a new cGMP production facility, more than 100 partner companies, and over 3,000 recombinant proteins produced.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Recombinant Protein Production
Antibody Humanization
Stable Cell Line Dev
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
QMC platform
Wave bioreactors
1,600 m2 cGMP production facility
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Icosagen Group located?
- Icosagen Group operates from Eerika tee 1, Õssu küla, Kambja vald, 61713 Tartumaa, Estonia, Tartu, Estonia.
- Who runs Icosagen Group?
- Icosagen Group is led by Mart Ustav, Founder and CEO. Verified 14 Mar 2026.
- What certifications does Icosagen Group hold?
- Icosagen Group is documented under GMP Certified (Manufacturing), ISO 9001.
- What does Icosagen Group do?
- 1,600 m² cGMP protein-manufacturing facility with QMC platform and wave bioreactors up to 1,200 L for discovery-to-manufacturing continuity. Core capabilities: Recombinant Protein Production, Antibody Humanization, Stable Cell Line Dev.
Editorial context
Related technical briefs
Briefs that name Tartu as a covered market or city.